Delivery Order SPE2DB24D2011-SPE2DB24FBQPB

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a $1,046.82 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,561,655,726 units of the prescription drug Dexmethylphenidate ER 10 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,531 units of Dexmethylphenidate ER 10 mg capsules. The $5,556.84 firm-fixed-price contract has an ultimate completion date of August 22, 2024. This contract is not a set-aside and is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,749,418 units of Dexmethylphenidate ER 25 mg Capsules. The contract has a firm fixed price of $7,006.25 and a period of performance through September 10, 2024. This award is under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of pharmaceutical and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,310,217 units of the generic drug dexmethylphenidate extended-release (ER) 5 milligram capsules. The firm-fixed-price contract has a ceiling value of $2,234.10 and an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a $3,528.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,426,360 units of the prescription medication dexmethylphenidate ER 5 mg capsules. The contract has a period of performance through May 30, 2025 and is not a set-aside contract. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,060,860 units of the drug Dexmethylphenidate ER 20 mg capsules, with a ceiling value of $4,639.84. The contract is a firm fixed-price delivery order, with a performance period ending on April 29, 2025. This contract is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,469,333 units of the prescription drug dexmethylphenidate extended-release 25 mg capsules. The contract has a firm fixed price of $8,201.50 and a completion date of August 16, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a $6,703.38 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,899,610 units of 10 mg dexmethylphenidate extended-release capsules, a medication used to treat attention-deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4566110911 - Dexmethylphenidate ER 10 mg capsules. The contract is a firm fixed price delivery order with a ceiling value of $1,323.07 and an ultimate completion date of October 16, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of Dexmethylphenidate ER 20 mg capsules. The contract is a firm-fixed price delivery order with a ceiling value of $1,493.32 and a completion date of June 5, 2025. The contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBQPB
    Delivery Order

This is a $2,234.07 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the supply of 4,565,231,348 units of Dexmethylphenidate ER 10 mg capsules. The contract has a performance period ending on July 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/22/24, 9:02 AM